Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 108

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 108
---
 requirements. The broker/dealer must make an individualized written suitability determination for the purchaser and receive the purchaser’s written consent prior to the transaction.

SEC regulations also require additional disclosure in connection with any trades involving a “penny stock,” including the delivery, prior to any penny stock transaction, of a disclosure schedule explaining the penny stock market and its associated risks. In addition, broker-dealers must disclose commissions payable to both the broker-dealer and the registered representative and current quotations for the securities they offer. The additional burdens imposed upon broker-dealers by such requirements may discourage broker-dealers from recommending transactions in our securities, which could severely limit the liquidity of our securities and consequently adversely affect the market price for our securities. In addition, few broker or dealers are likely to undertake these compliance activities. Other risks associated with trading in penny stocks could also be price fluctuations and the lack of a liquid market. See “Risk Factors” on page 5.

<div align='center'>LEGAL MATTERS</div>

The validity of the Common Stock offered hereby will be passed upon by The Crone Law Group, P.C.

<div align='center'>EXPERTS</div>

The consolidated financial statements of Lipovation
Ltd as Revium Rx (predecessor) as of July 23, 2024 and for the period ended July 23, 2024, and for the years ended December 31, 2023 and
2022, included in this prospectus and in the registration statement have been so included in reliance on the report of Ziv Haft, BDO member
firm, an independent registered public accounting firm, appearing elsewhere herein and in the Registration Statement.

The consolidated financial statements of Revium
RX as of December 31, 2023 and for the two years in the period ended December 31, 2023, included in this prospectus and in the registration
statement have been so included in reliance on the report of Ziv Haft, BDO member firm, an independent registered public accounting firm,
appearing elsewhere herein and in the Registration Statement.

<div align='center'>67

ADDITIONAL INFORMATION</div>

We have filed with the SEC this registration statement on Form S-1 under the Securities Act with respect to the shares of Common Stock being offered by this Prospectus. This Prospectus, which constitutes a part of this registration statement, does not contain all of the information in this registration statement and its exhibits. For further information with respect to us and the Common Stock offered by this Prospectus